Phase 3 Respiratory Syncytial Virus (RSV) Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.
Respiratory Syncytial Virus (RSV)
Pfizer130 enrolled5 locationsNCT07543380
Recruiting
Phase 3
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
Respiratory Syncytial Virus (RSV)
MAXVAX Biotechnology Limited Liability Company25,000 enrolled8 locationsNCT07272434